FMP
Genprex, Inc.
GNPX
NASDAQ
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
0.89 USD
-0.0382 (-4.29%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Ryan M. Confer M.S.
sector
Healthcare
industry
Biotechnology
website
https://www.genprex.comexchange
NASDAQ
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
CIK
0001595248
ISIN
US3724462037
CUSIP
372446104
Address
3300 Bee Cave Road
Phone
877 774 4679
Country
US
Employee
21
IPO Date
Mar 29, 2018
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
GNPX Financial Summary
CIK
0001595248
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
372446104
ISIN
US3724462037
Country
US
Price
0.89
Beta
-1.29
Volume Avg.
9.72M
Market Cap
7.57M
Shares
-
52-Week
0.281-14.4
DCF
4.93
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.08
P/B
-
Website
https://www.genprex.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest GNPX News
It looks like there's no news available.
